FDA Inspection 711361 — Prescript Pharmaceuticals, Inc.

Prescript Pharmaceuticals, Inc. — FEI 1000135824

The FDA completed an inspection of Prescript Pharmaceuticals, Inc. on Mar 3, 2011 in Pleasanton, CA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Mar 3, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pleasanton, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.